Close Menu
Healthtost
  • News
  • Mental Health
  • Men’s Health
  • Women’s Health
  • Skin Care
  • Sexual Health
  • Pregnancy
  • Nutrition
  • Fitness
What's Hot

15 easy ways to get 20 grams of protein (Personal Trainer Guide)

June 29, 2025

Organ chip technology accurately predicts chemotherapy response to patients with esophageal adenocarcinoma

June 29, 2025

How Barefoot Workout can make you stronger, more athletic and stunning in injuries

June 29, 2025
Facebook X (Twitter) Instagram
  • About Us
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Disclaimer
Facebook X (Twitter) Instagram
Healthtost
SUBSCRIBE
  • News

    Organ chip technology accurately predicts chemotherapy response to patients with esophageal adenocarcinoma

    June 29, 2025

    Expansion of genetic code to mammalian cells using pseuduridine -modified codons

    June 29, 2025

    Discover a Dimmer Genetic switch that controls fetal growth

    June 28, 2025

    Who Scientific Advisory Group for the origin of new pathogenic reports for Sars-Cov-2 Origins

    June 28, 2025

    Exploring nervous reactions to mental exhaustion in healthy adults

    June 27, 2025
  • Mental Health

    Which one is right for you? – Talkspace

    June 27, 2025

    Do alternative treatments for bipolar disorder work? Guide based on evidence (2025)

    June 26, 2025

    Data reveals both challenges and positive trends

    June 16, 2025

    How to choose the best yoga teacher training in Rishikesh

    June 14, 2025

    Stress is the most common mental health problem – here is how technology could help manage

    June 11, 2025
  • Men’s Health

    How Barefoot Workout can make you stronger, more athletic and stunning in injuries

    June 29, 2025

    How I turned the chatgpt to my personal nutrition coach and you can also

    June 29, 2025

    Total human care is here: Help men look and feel great now and forever

    June 28, 2025

    Why men ignore sleep apnea (and what they really cost them) – talking about men’s health

    June 28, 2025

    Lessons from a survivor for prostate cancer

    June 26, 2025
  • Women’s Health

    Books I have recently read – The Fitnessista

    June 29, 2025

    Does it support your aesthetic travel your body and mind? Guide

    June 28, 2025

    Eating for real immune support this winter

    June 27, 2025

    What does public health really mean

    June 27, 2025

    How long do you have to expand after MTF? A complete driver to expand – Vuvatech

    June 25, 2025
  • Skin Care

    Sunburn First Aid -7 common mistakes you will regret later

    June 29, 2025

    What is happening first? The step by step guide to build a routine of skin care

    June 28, 2025

    DIY Vitamin C Cucumber The Eye Serum

    June 27, 2025

    Tips for Summer skin care for your best skin

    June 26, 2025

    How a crisis of ingredients led to the best physical form of our deodorant stick

    June 24, 2025
  • Sexual Health

    Can Koles really get chlamydia?

    June 28, 2025

    Overward Visitor and Student Health Insurance in Australia for visa holders

    June 27, 2025

    Disassociation of the latest testosterone treatment lines

    June 27, 2025

    We always know that orgasms were good for you. Now there is proof.

    June 26, 2025

    Josh Duhamel gets testosterone replacement treatment at 52

    June 25, 2025
  • Pregnancy

    AI helps the couple capture after 19 years and 15 IVF attempts

    June 29, 2025

    7 signs your gut can be out of balance

    June 29, 2025

    Helping parents prepare for birth with calm and trust

    June 28, 2025

    Better screen limits for kids: Expert driver for parents

    June 28, 2025

    What is prenatal ability?

    June 27, 2025
  • Nutrition

    25 best vegan taco recipes that are healthy, easy and full of flavor

    June 29, 2025

    Episode 004: Trust your truth against all logic with Angela de la Agua

    June 28, 2025

    Benefits for the health of CoQ10 you should be aware

    June 27, 2025

    Creatine Completion in Menopause: What does science say?

    June 27, 2025

    GLP-1 Enhance the Smoothie recipes push for weight loss

    June 26, 2025
  • Fitness

    15 easy ways to get 20 grams of protein (Personal Trainer Guide)

    June 29, 2025

    Review of the Heat Index: an approach based on evidence

    June 28, 2025

    Bodybuilding Legend Charles Glass’ 5 Favorite Movements Hamstring

    June 27, 2025

    7 Best energy gels 2025, per runners and dieticians

    June 26, 2025

    Different types of training and fitness courses

    June 25, 2025
Healthtost
Home»News»Clinical trial shows CRISPR gene editing has exciting potential for treating a rare form of blindness
News

Clinical trial shows CRISPR gene editing has exciting potential for treating a rare form of blindness

healthtostBy healthtostMay 8, 2024No Comments6 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Reddit WhatsApp Email
Clinical Trial Shows Crispr Gene Editing Has Exciting Potential For
Share
Facebook Twitter LinkedIn Pinterest WhatsApp Email

Retinal degeneration can be hereditary or acquired. In the first case, it is an incurable and progressive condition. A recent study published in The New England Journal of Medicine investigated the potential use of gene editing to correct a congenital retinal degeneration called CEP290 that causes early vision loss.

Study: Gene editing for CEP290-Associated Retinal Degeneration. Image credit: CI Photos/Shutterstock.com

Record

Hereditary retinal degenerations are caused by pathogenic mutations in any of 280 genes. These mutations cause the photoreceptors (the cone and rod cells that respond to light) of the retina to malfunction and die, resulting in impaired vision in affected individuals. These conditions are a leading cause of blindness worldwide.

In the condition called CEP290-related hereditary retinal degeneration, or Leber congenital macular degeneration, centrosomal protein 290 (CEP290) is mutated, leading to partial or complete blindness within the first ten years of life. This is, therefore, the leading cause of genetic retinal blindness in children.

A single gene variant called p.Cys998X accounts for more than three-quarters of people with the condition in the US alone. Normal CEP290 is prevented by the insertion of a single coding segment during transcription. Deficiency of this molecule disrupts normal ciliary action in photoreceptors.

There is currently no cure. Supportive care includes the use of magnifying glasses and Braille with home modifications to promote a safe environment for the visually impaired person.

At the tissue level, rods and cones show a loss of organization in the outer retinal segments secondary to the absence of sensory cilia in this condition. Rods in the mesoperipheral retina die, while cones remain in the macula, the center of the retina.

There is a characteristic disconnection between retinal structure and function in these patients. Proximal elements of the visual pathway remain intact, indicating that the photoreceptors in these eyes could be used to restore vision. Various approaches that have been explored include using antisense oligonucleotides to prevent expression of the inserted exon (expressed coding segment) or delivering the micro-version of the CEP290 gene into the cell.

A newer technology makes use of gene editing by injecting EDIT-101. It is based on the use of clustered regularly interspaced short palindromic repeats (CRISPR) in combination with CRISPR-associated protein 9 (Cas9) to eliminate the pathogenic variant IVS26. The current study aimed to examine the safety and efficacy of this treatment.

About the study

The researchers chose to conduct an open-label study in which participants received individual doses of the drug in ascending order of dosage. This phase 1-2 study aimed to assess the safety of the drug, while secondary efficacy outcomes were also assessed.

Safety outcomes included adverse events and unacceptable toxicities that precluded use of the dose of interest. Efficacy was measured in several ways, including corrected visual acuity, retinal sensitivity, vision-related quality of life score, and visual navigation motor test.

The EDIT-101 gene was injected into 12 adults and two children. The adults ranged in age from 17 to 63, and the children were nine and fourteen, respectively. All had at least one copy of the IV26 variant.

Doses ranged from 6×1011 vector genomes [vg] per mL to 1×1012 vg per mL at 3×1012 vg per mL. Two, five, and five adults received low, intermediate, and high doses, respectively. Children received the intermediate dose.

All injections were made in the worse performing eye, the study eye.

What did the study show?

Most participants had severe visual acuity loss below 1.6 logMAR. As a result, visual acuity could only be tested with the Berkeley Rudimentary Vision test. At least 3 units of recording increased spectral sensitivity and rod function was undetectable in all participants.

However, the thickness of the photoreceptor layer was within normal limits in most of the patients, as expected.

Most side effects were mild, with about one-fifth moderate and only about 40% treatment-related. There were no serious adverse treatment effects and no dose-limiting toxicities. The structure of the retina did not show any adverse changes, which proved the acceptable safety of the drug.

In terms of its effectiveness, this preliminary study showed significant improvements in cone vision from baseline in six patients. Of these, five also showed at least one other area of ​​improvement.

Improvement in at least one of the following areas (best-corrected visual acuity, red light sensitivity, or vision-based mobility) was noted in nine of the patients, or almost two out of three in the entire group. Almost 80% had improvements in at least one efficacy-related outcome and six in two or more outcomes.

Four had a 0.3 logMAR increase in best-corrected visual acuity, thus meeting criteria for a clinically significant improvement. Of these, three reported improvement as early as the third month after the injection. The mean change in this parameter in the whole group was -0.21 logMAR.

For almost half the group (6/14), cone sensitivity to light at various frequencies, red, white and blue, showed a visually significant increase in the study eye over the control eye, some as early as three months later. All had received intermediate to high doses. In two, improvement reached >1 logMAR, the maximum possible for cones only.

Cone-induced sensitivity was greater in patients more severely affected at baseline. Almost all patients with improved cone function also showed improvement in one or more other outcomes.

Four participants had a visually significant improvement in their ability to navigate more complex lessons than at baseline, with one of them continuing to show this improvement for at least two years.

In six participants, clinically significant increases in vision-related quality of life scores were observed.

“These findings support the presence of productive in vivo gene editing by EDIT-101, therapeutic levels of CEP290 protein expression, and enhanced cone photoreceptor function.”

conclusions

This small study showed a high safety profile and better visual function in terms of photoreceptor function after EDIT-101 was administered to participants. These findings “support further research of in vivo CRISPR-Cas9 gene editing to treat inherited retinal degenerations due to the IVS26 variant of CEP290 and other genetic causes.”

Areas of concern that warrant further investigation include the finding that better cone function after treatment is not synonymous with better visual acuity, which is the clinically relevant outcome. Second, earlier intervention may have better results. Finally, if both copies of the gene are targeted, the therapeutic benefit may be greater.

Journal Reference:

  • Pierce, EA, Aleman, TS, Jayasundera, KT, et al. GeneEditing for CEP290-associated retinal degeneration. The New England Journal of Medicine 2024. doi: 10.1056/NEJMoa2309915.
blindness clinical CRISPR editing exciting form gene potential Rare shows treating Trial
bhanuprakash.cg
healthtost
  • Website

Related Posts

Organ chip technology accurately predicts chemotherapy response to patients with esophageal adenocarcinoma

June 29, 2025

Expansion of genetic code to mammalian cells using pseuduridine -modified codons

June 29, 2025

Discover a Dimmer Genetic switch that controls fetal growth

June 28, 2025

Leave A Reply Cancel Reply

Don't Miss
Fitness

15 easy ways to get 20 grams of protein (Personal Trainer Guide)

By healthtostJune 29, 20250

The acquisition of several proteins in your diet is vital to muscle repair, satiety and…

Organ chip technology accurately predicts chemotherapy response to patients with esophageal adenocarcinoma

June 29, 2025

How Barefoot Workout can make you stronger, more athletic and stunning in injuries

June 29, 2025

Books I have recently read – The Fitnessista

June 29, 2025
Stay In Touch
  • Facebook
  • Twitter
  • Pinterest
  • Instagram
  • YouTube
  • Vimeo
TAGS
Baby benefits body brain cancer care Day Diet disease exercise finds Fitness food Guide health healthy heart Life Loss Men mental Natural Nutrition Patients Pregnancy protein research reveals Review risk routine sex sexual Skin study Therapy Tips Top Training Treatment Understanding ways weight women Workout
About Us
About Us

Welcome to HealthTost, your trusted source for breaking health news, expert insights, and wellness inspiration. At HealthTost, we are committed to delivering accurate, timely, and empowering information to help you make informed decisions about your health and well-being.

Latest Articles

15 easy ways to get 20 grams of protein (Personal Trainer Guide)

June 29, 2025

Organ chip technology accurately predicts chemotherapy response to patients with esophageal adenocarcinoma

June 29, 2025

How Barefoot Workout can make you stronger, more athletic and stunning in injuries

June 29, 2025
New Comments
    Facebook X (Twitter) Instagram Pinterest
    • About Us
    • Contact Us
    • Privacy Policy
    • Terms and Conditions
    • Disclaimer
    © 2025 HealthTost. All Rights Reserved.

    Type above and press Enter to search. Press Esc to cancel.